Management of Pseudomonas Aeruginosa Related Infection in Emergency Department

Pseudomonas aeruginosa relating infection has high mortality rate in health care setting. In particular, immunocompromised and critically ill patients. Recent studies suggested considering broad-spectrum antipseudomonal antibiotics for Gram-negative bacteria coverage in the emergency Department, especially for high-risk patients. A number of studies have been conducted to assess risk factors of resistance.This review will evaluate the available antipseudomonal antibiotic along with its resistant pattern. Also it will discuss selected antipseudomonal agent in managing Multidrug resistant duo to Pseudomonas aeruginosa. The review will discuss the Drug selection approaches for patients with neutropenia, pneumonia, and urinary tract infections. The last part in the review will highlight the preferred empirical antipseudomonal antibiotic used at Emergency Department.